The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.
Open accessAbstract
Metabolic and vascular factors have been invoked in the pathogenesis of diabetic neuropathy but their interrelationships are poorly understood. Both aldose reductase inhibitors and vasodilators improve nerve conduction velocity, blood flow, and (Na+,K+)-ATPase activity in the streptozotocin diabetic rat, implying a metabolic-vascular interaction. NADPH is an obligate cofactor for both aldose reductase and nitric oxide synthase such that activation of aldose reductase by hyperglycemia could limit nitric oxide synthesis by cofactor competition, producing vasoconstriction, ischemia, and slowing of nerve conduction. In accordance with this construct, N-nitro-L-arginine methyl ester, a competitive inhibitor of nitric oxide synthase reversed the increased nerve conduction velocity afforded by aldose reductase inhibitor treatment in the acutely diabetic rat without affecting the attendant correction of nerve sorbitol and myo-inositol. With prolonged administration, N-nitro-L-arginine methyl ester fully reproduced the nerve conduction slowing and (Na+,K+)-ATPase impairment characteristic of diabetes. Thus the aldose reductase-inhibitor-sensitive component of conduction slowing and the reduced (Na+,K+)-ATPase activity in the diabetic rat may reflect in part impaired nitric oxide activity, thus comprising a dual metabolic-ischemic pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP
Rapoport, R. M., & Murad, F. (1983) · Circulation Research · doi:10.1161/01.res.52.3.352 · Cited by 928
Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain
Bazán, N. G. (1970) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(70)90086-x · Cited by 855
Greene, D. A., & Lattimer, S. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111030 · Cited by 244 · cited 5×
“Thus, in contrast to its potent anti-ARI effect, L-NAME did not block the beneficial effect of dietary MI on NCVin D rats (9).”
BackgroundMethodInfluentialSelf-citation
Cited by
Yabe-Nishimura, C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01347-4 · Cited by 526
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Stevens, M. J., Obrosova, I., Cao, X., Van Huysen, C., & Greene, D. A. (2000) · Diabetes · doi:10.2337/diabetes.49.6.1006 · Cited by 366
Self-citationVeves, A., Akbari, C. M., Primavera, J., Donaghue, V. M., Zacharoulis, D., Chrzan, J. S., DeGirolami, U., LoGerfo, F. W., & Freeman, R. (1998) · Diabetes · doi:10.2337/diabetes.47.3.457 · Cited by 349
The pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 344
Metadata
- Authors
- Stevens, M. J., Dananberg, J., Feldman, E. L., Lattimer, S. A., Kamijo, M., Thomas, T. P., Shindo, H., Sima, A. A., & Greene, D. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-08-01
- Volume
- 94
- Issue
- 2
- Pages
- 853-859
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2152826676
- Cited by
- 208
- References
- 4
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.